• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].

作者信息

Kalashnikov A Ia, Kon'kova T A, Popovkin N N, Iarmolinskiĭ I S

出版信息

Urol Nefrol (Mosk). 1989 May-Jun(3):46-52.

PMID:2773181
Abstract

To follow calcium metabolism in patients with a terminal stage of chronic renal failure who are on hemodialysis treatment is necessary for the assessment of phosphorus/calcium metabolism in a whole, efficiency of conservative treatment, indications to surgical intervention (parathyroidectomy, renal allotransplantation). The investigation included the assessment of total and ionized calcium blood plasma levels with regard to hemodialysis duration; the correlation of clinical and roentgenological picture of secondary hyperparathyroidism. A total of 222 patients were observed, and with regard to hemodialysis duration allocated into 5 groups: in the first hemodialysis lasted for not more than 3 mos; in the second--from 3 mos to 1 yr; third group with its duration from 1 to 2 yrs; fourth, when it lasted from 2 to 3 yrs; and the fifth group--hemodialysis lasted for more than 3 yrs. It was documented that disorders in calcium metabolism were increasing in parallel with the duration of hemodialysis. Clinical and roentgenological picture of hyperparathyroidism was accompanied by an evident increment of blood plasma ionized calcium while the levels of total blood calcium were but slightly changed. As a part of combined diagnosis ionized calcium assessment is helpful in early prevention and management of calcium metabolism disorders.

摘要

相似文献

1
[The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].
Urol Nefrol (Mosk). 1989 May-Jun(3):46-52.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
[The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
Urol Nefrol (Mosk). 1997 May-Jun(3):23-5.
4
[Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Med Tekh. 1991 Jan-Feb(1):27-9.
5
[Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
Rev Iber Endocrinol. 1976 Nov-Dec;23(138):535-55.
6
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能和结构的密切关联。
J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):3-8.
7
Is anemia of chronic renal failure related to secondary hyperparathyroidism?
Arch Intern Med. 1981 Mar;141(4):453-5.
8
Secondary hyperparathyroidism in chronic renal failure.慢性肾衰竭中的继发性甲状旁腺功能亢进
Scand J Urol Nephrol Suppl. 1983;70:1-63.
9
Determinants of arterial compliance in patients treated by hemodialysis.血液透析治疗患者动脉顺应性的决定因素
Clin Nephrol. 2001 Dec;56(6):435-44.
10
A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.血液透析患者继发性甲状旁腺功能亢进早期使用骨化三醇治疗的对照试验。
Clin Nephrol. 2000 Oct;54(4):301-8.